These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29908880)

  • 1. Microphysiological systems meet hiPSC technology - New tools for disease modeling of liver infections in basic research and drug development.
    Raasch M; Fritsche E; Kurtz A; Bauer M; Mosig AS
    Adv Drug Deliv Rev; 2019 Feb; 140():51-67. PubMed ID: 29908880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Isogenic Human Induced Pluripotent Stem Cell-Based Liver and Heart Microphysiological Systems Predict Unsafe Drug-Drug Interaction.
    Lee-Montiel FT; Laemmle A; Charwat V; Dumont L; Lee CS; Huebsch N; Okochi H; Hancock MJ; Siemons B; Boggess SC; Goswami I; Miller EW; Willenbring H; Healy KE
    Front Pharmacol; 2021; 12():667010. PubMed ID: 34025426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microphysiological systems in early stage drug development: Perspectives on current applications and future impact.
    Kopec AK; Yokokawa R; Khan N; Horii I; Finley JE; Bono CP; Donovan C; Roy J; Harney J; Burdick AD; Jessen B; Lu S; Collinge M; Sadeghian RB; Derzi M; Tomlinson L; Burkhardt JE
    J Toxicol Sci; 2021; 46(3):99-114. PubMed ID: 33642521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consideration of Commercially Available Hepatocytes as Cell Sources for Liver-Microphysiological Systems by Comparing Liver Characteristics.
    Horiuchi S; Kuroda Y; Komizu Y; Ishida S
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting.
    Ma X; Qu X; Zhu W; Li YS; Yuan S; Zhang H; Liu J; Wang P; Lai CS; Zanella F; Feng GS; Sheikh F; Chien S; Chen S
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2206-11. PubMed ID: 26858399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered Platforms for Maturing Pluripotent Stem Cell-Derived Liver Cells for Disease Modeling.
    Yuan Y; Cotton K; Samarasekera D; Khetani SR
    Cell Mol Gastroenterol Hepatol; 2023; 15(5):1147-1160. PubMed ID: 36738860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Microphysiological Systems for Predicting and Evaluating Drug Effects.
    Ribeiro AJS; Yang X; Patel V; Madabushi R; Strauss DG
    Clin Pharmacol Ther; 2019 Jul; 106(1):139-147. PubMed ID: 30993668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilizing microphysiological systems and induced pluripotent stem cells for disease modeling: a case study for blood brain barrier research in a pharmaceutical setting.
    Fabre KM; Delsing L; Hicks R; Colclough N; Crowther DC; Ewart L
    Adv Drug Deliv Rev; 2019 Feb; 140():129-135. PubMed ID: 30253201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development.
    Marx U; Akabane T; Andersson TB; Baker E; Beilmann M; Beken S; Brendler-Schwaab S; Cirit M; David R; Dehne EM; Durieux I; Ewart L; Fitzpatrick SC; Frey O; Fuchs F; Griffith LG; Hamilton GA; Hartung T; Hoeng J; Hogberg H; Hughes DJ; Ingber DE; Iskandar A; Kanamori T; Kojima H; Kuehnl J; Leist M; Li B; Loskill P; Mendrick DL; Neumann T; Pallocca G; Rusyn I; Smirnova L; Steger-Hartmann T; Tagle DA; Tonevitsky A; Tsyb S; Trapecar M; Van de Water B; Van den Eijnden-van Raaij J; Vulto P; Watanabe K; Wolf A; Zhou X; Roth A
    ALTEX; 2020; 37(3):365-394. PubMed ID: 32113184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microphysiological Systems: A Pathologist's Perspective.
    Sura R; Van Vleet T; Berridge BR
    Vet Pathol; 2020 May; 57(3):358-368. PubMed ID: 32180532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery.
    Tricot T; Verfaillie CM; Kumar M
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioprinting of human pluripotent stem cells and their directed differentiation into hepatocyte-like cells for the generation of mini-livers in 3D.
    Faulkner-Jones A; Fyfe C; Cornelissen DJ; Gardner J; King J; Courtney A; Shu W
    Biofabrication; 2015 Oct; 7(4):044102. PubMed ID: 26486521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments.
    Wang B; Jakus AE; Baptista PM; Soker S; Soto-Gutierrez A; Abecassis MM; Shah RN; Wertheim JA
    Stem Cells Transl Med; 2016 Sep; 5(9):1257-67. PubMed ID: 27421950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro differentiation of pluripotent stem cells into hepatocyte like cells - Basic principles and current progress.
    Graffmann N; Scherer B; Adjaye J
    Stem Cell Res; 2022 May; 61():102763. PubMed ID: 35395623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human brain microphysiological systems in the study of neuroinfectious disorders.
    Barreras P; Pamies D; Hartung T; Pardo CA
    Exp Neurol; 2023 Jul; 365():114409. PubMed ID: 37061175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Merging organoid and organ-on-a-chip technology to generate complex multi-layer tissue models in a human retina-on-a-chip platform.
    Achberger K; Probst C; Haderspeck J; Bolz S; Rogal J; Chuchuy J; Nikolova M; Cora V; Antkowiak L; Haq W; Shen N; Schenke-Layland K; Ueffing M; Liebau S; Loskill P
    Elife; 2019 Aug; 8():. PubMed ID: 31451149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfluidic technology enhances the potential of human pluripotent stem cells.
    Gagliano O; Elvassore N; Luni C
    Biochem Biophys Res Commun; 2016 May; 473(3):683-7. PubMed ID: 26772885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system.
    Wang Y; Wang H; Deng P; Chen W; Guo Y; Tao T; Qin J
    Lab Chip; 2018 Dec; 18(23):3606-3616. PubMed ID: 30357207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytes.
    Haile Y; Nakhaei-Nejad M; Boakye PA; Baker G; Smith PA; Murray AG; Giuliani F; Jahroudi N
    PLoS One; 2015; 10(3):e0119617. PubMed ID: 25789622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.